Ophthalmologica

Original Paper

Free Access

Photic Maculopathy Resulting from the Light of a Video Camera in Patients Taking Triazolam

Miyagawa M. · Hayasaka S. · Noda S.

Author affiliations

Department of Ophthalmology, Shimane Medical University, Izumo, Japan

Corresponding Author

Mayumi Miyagawa, MD, Department of Ophthalmology, Shimane Medical University, Izumo, Shimane 693 (Japan)

Related Articles for ""

Ophthalmologica 1994;208:145–146

Abstract

Two patients gazed at the bright light of a video camera. Both patients had been taking triazolam. Decreased visual acuity and macular lesions were found in the affected eyes of the patients. The maculopathy in 1 patient (case 1) was irreversible, but that in case 2 recovered. Photic maculopathy from the light of a video camera may be rare.

© 1994 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 09, 1993
Accepted: February 11, 1994
Published online: April 01, 2010
Issue release date: 1994

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 0030-3755 (Print)
eISSN: 1423-0267 (Online)

For additional information: https://www.karger.com/OPH


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP